Metabolic tumour volume as prognostic factor for early response to treatment in advanced stage Hodgkin lymphoma

被引：0
|
作者：
Kreissl, S. [1 ,2 ]
Mueller, H. [2 ]
Voltin, C. -A. [3 ]
Baues, C. [2 ,4 ]
Klaeser, B. [5 ]
Moccia, A. [6 ,7 ]
Borchmann, P. [1 ,2 ]
Engert, A. [1 ,2 ]
Kuhnert, G. [3 ]
Drzezga, A. [3 ]
Dietlein, M. [2 ,3 ]
Kobe, C. [2 ,3 ]
Mettler, J. [2 ,3 ]
机构：
[1] Uniklin Koln, Innere Med 1, Cologne, Germany
[2] German Hodgkin Study Grp GHSG, Cologne, Germany
[3] Uniklin Koln, Abt Nukl Med, Cologne, Germany
[4] Uniklin Koln, Abt Strahlentherapie, Cologne, Germany
[5] Bern Univ Hosp, Inselspital, Bern, Switzerland
[6] Oncol Inst Southern Switzerland, Med Onkol, Bellinzona, Switzerland
[7] Swiss Grp Clin Canc Res, Bern, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P432
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [21] Prediction of toxicity using metabolic tumor volume and body composition analysis in patients with advanced stage Hodgkin lymphoma undergoing treatment with BVAVD
    Kuker, Russ
    Stanchina, Michele
    Han, Sunwoo
    Polar, Mark
    Uribe, Laura Palacio
    Crane, Tracy
    Yang, Fei
    Moskowitz, Craig
    Alderuccio, Juan
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [22] Trends in the Treatment of Early-Stage Hodgkin Lymphoma
    Barton, Mary Kay
    CA-A CANCER JOURNAL FOR CLINICIANS, 2015, 65 (04) : 253 - 254
  • [23] Treatment of early-stage nonbulky Hodgkin lymphoma
    Straus, David J.
    CURRENT OPINION IN ONCOLOGY, 2006, 18 (05) : 432 - 436
  • [24] Treatment of early stage favorable and unfavorable Hodgkin lymphoma
    Sasse, S.
    Momotow, J.
    Broeckelmann, P. J.
    Baues, C.
    Eich, H. T.
    Engert, A.
    ONKOLOGIE, 2022, 28 (10): : 879 - 888
  • [25] Metabolic Tumor Volume for Early Response Assessment in Early-Stage Unfavorable Hodgkin Lymphoma Treated with Nivolumab in the GHSG Nivahl Phase II Trial
    Voltin, Conrad-Amadeus
    Mettler, Jasmin
    Mueller, Horst
    Fuchs, Michael
    Baues, Christian
    Dietlein, Markus
    Engert, Andreas
    Borchmann, Peter
    Kobe, Carsten
    Brockelmann, Paul J.
    BLOOD, 2019, 134
  • [26] BIOLOGICAL B STAGE AS A PROGNOSTIC FACTOR FOR OUTCOME IN CHILDHOOD HODGKIN LYMPHOMA
    Kulyova, S.
    Karytsky, A.
    Kolygin, B.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 83 - 83
  • [27] Bone Involvement: A Poor Prognostic Factor in Stage IV Hodgkin Lymphoma
    Abou Yehia, Z.
    Tang, C.
    Milgrom, S. A.
    Fanale, M.
    Smith, G. L.
    Pinnix, C. C.
    Reddy, J.
    Akhtari, M.
    Gunther, J. R.
    Osborne, E. M.
    Ahmed, S.
    Dabaja, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E456 - E456
  • [28] Early stage Hodgkin lymphoma
    Radford, John
    HEMATOLOGICAL ONCOLOGY, 2015, 33 : 84 - 86
  • [29] Review of Treatment Options for the Management of Advanced Stage Hodgkin Lymphoma
    Vellemans, Helene
    Andre, Marc P. E.
    CANCERS, 2021, 13 (15)
  • [30] Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Moskowitz, Alison J.
    Schoder, Heiko
    Gavane, Somali
    Thoren, Katie L.
    Fleisher, Martin
    Yahalom, Joachim
    McCall, Susan J.
    Cadzin, Briana R.
    Fox, Stephanie Y.
    Gerecitano, John
    Grewal, Ravinder
    Hamlin, Paul A.
    Horwitz, Steven M.
    Kumar, Anita
    Matasar, Matthew
    Ni, Andy
    Noy, Ariela
    Palomba, M. Lia
    Perales, Miguel-Angel
    Portlock, Carol S.
    Sauter, Craig
    Straus, David
    Younes, Anas
    Zelenetz, Andrew D.
    Moskowitz, Craig H.
    BLOOD, 2017, 130 (20) : 2196 - 2203
12345